Influence of the Hepatitis B e Antigen/ Anti-HBe Status on the Response to Lamivudine

Publisher： Karger

E-ISSN： 1423-0100|46|6|339-343

ISSN： 0300-5526

Source： Intervirology, Vol.46, Iss.6, 2003-12, pp. : 339-343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimization of lamivudine therapy

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 4, 2015-04 ,pp. : 748-755

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Results of Lamivudine Monotherapy in Korean Patients with HBeAg-Positive Chronic Hepatitis B: Response and Relapse Rates, and Factors Related to Durability of HBeAg Seroconversion

By  

Intervirology, Vol. 48, Iss. 6, 2005-07 ,pp. : 341-349

Karger

Access to resources Recommend Favorite

P064: Hepatitis B surface Antigen (HBsAg) levels in chronic hepatitis B patients ‐ a comparison between patients of different ages and their hepatitisBeAntigen (HBeAg) seroconversion status in a prospective cohort

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 52-52

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatitis B Virus DNA in Anti-HBe-Positive Asymptomatic Carriers

By  

Intervirology, Vol. 46, Iss. 1, 2003-02 ,pp. : 43-49

Karger

Access to resources Recommend Favorite

Higher pretherapy and significant decrease during the first 12 months of therapy in serum laminin levels may associate with hepatitis B e antigen seroconversion in chronic hepatitis B patients treated with lamivudine

By Han Qunying   Lou Sai   Liu Zhengwen   Zhang Ni   Zhang Guoyu   Lv Yi   Duan Shaoqiong   Li Zhu  

Clinical and Experimental Medicine, Vol. 10, Iss. 4, 2010-12 ,pp. : 245-251

Springer Publishing Company

Access to resources Recommend Favorite